Back to search

University of British Columbia

Investigating early life immunity and vaccine response using high-dimensional biological (omics) datasets

Abstract

dc:description

Early life immune system varies both in quality and quantity compared to an average adult’s, making neonates (< 28 days old) vulnerable to infections. These differences can also lead to an inefficient immune response to vaccines, such as the hepatitis B vaccine (HBV), especially in resource-poor settings with inadequate immunization. Neonatal vaccine responses are often boosted with multiple doses or by co-administration with other vaccines, such as Bacille Calmette-Guérin (BCG), which can act as an adjuvant due to its non-specific effects on the immune system. While some neonates elicit optimal vaccine response, others do not, highlighting the need for a better understanding of early-life immunity and its interactions with vaccines. In this thesis, I utilized data-driven approaches to investigate the early-life immune system and vaccine response. I analyzed high-dimensional biological (omics) datasets derived from the first week-of-life blood samples at both the single- and integrated-multi-omics levels, aiming to identify signatures associated with anti-hepB antibody titers, understand vaccine schedule impacts, and study the influence of sickle-cell trait (SCT) on neonatal immunity and vaccine responses. Additionally, I examined omics data from in vitro experiments to gain insights into neonate-specific immune changes induced by HBV, given with or without the BCG vaccine, and the mRNA vaccine for SARS-CoV-2, BNT162b2. Administering BCG with HBV induced a stronger vaccine response in neonates, demonstrated by higher in vivo anti-hepB antibody titers and more pronounced immune-associated differences in in vitro omics profiles with BCG-based treatments. I identified links between strong vaccine response and specific innate immune pathways, such as neutrophil degranulation, IL-1 signaling, and complement cascades. Compared to wild-type, SCT neonates showed omics-based changes associated with hepatic, renal, hematological pathways, and sickle-cell disease. For the BNT162b2 vaccine, neonates exhibited similarities to the cytokine profile of elders but had a decreased Th1-based activity compared to both adults and elders. This thesis demonstrated the utility of data-driven bioinformatics approaches to de-risk and accelerate early vaccine development and optimization by identifying targets for future hypothesis-driven vaccine studies. These findings will aid efforts to protect neonates from infectious diseases worldwide.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Experimental Medicine
Grantor dc:publisher
University of British Columbia
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Checkervarty, Abhinav Kumar
Contributors dc:contributor
  • Tebbutt, Scott J.
  • Cohen Freue, Gabriela V.

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/90053

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Checkervarty, Abhinav Kumar. Investigating early life immunity and vaccine response using high-dimensional biological (omics) datasets. doctoral thesis, University of British Columbia, 2024. http://hdl.handle.net/2429/90053